Kim, J.-H.

Yonsei University · Yonsei University Health System · Yonsei Cancer Hospital

1 paper on CoChatORCID 0000-0001-9061-3350

Most cited papers

Verified
A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)
Blumenschein, G. R., Smit, E. F., Planchard, D., Kim, D.-W., Cadranel, J., De Pas, T., Dunphy, F., Udud, K., Ahn, M.-J., Hanna, N. H., et al. (2015) · Annals of Oncology
Lung Cancer Treatments and MutationsLung Cancer Research Studies
Cited by 349

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free